The NHS under-invests at its peril

pharmafile | February 1, 2008 | Feature | |  NHS, healthcare, investment 

Related Content

ESTEVE CDMO adds $17.5m to Illinois expansion

ESTEVE CDMO is investing a further $17.5m to expand capacity and containment capabilities at its …

NIHR chief scientific adviser visits Huddersfield health innovation campus

Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health and Social Care and …

Five Facts about NHS and primary care

1 Primary care is the front door to the NHS, but it extends well beyond …

The Gateway to Local Adoption Series

Latest content